ENXTPA:DBVBiotechs
A Look At DBV Technologies (ENXTPA:DBV) Valuation As New VIASKIN Peanut Data Heads To AAAAI 2026
DBV Technologies (ENXTPA:DBV) is back in focus as it prepares to share fresh VITESSE Phase 3 data on its VIASKIN Peanut Patch at the 2026 AAAAI Annual Meeting, spotlighting peanut allergy treatment in young children.
See our latest analysis for DBV Technologies.
Those upcoming VITESSE Phase 3 readouts and recent conference appearances come after a sharp shift in sentiment, with the share price at €3.56, a 90 day share price return of 48.95% and a 1 year total shareholder return above 300%,...